{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T01:03:58Z","timestamp":1787879038708,"version":"build-2784847793"},"reference-count":54,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oral and Maxillofacial Surgery Clinics of North America"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/j.coms.2013.09.010","type":"journal-article","created":{"date-parts":[[2013,11,25]],"date-time":"2013-11-25T10:24:45Z","timestamp":1385375085000},"page":"63-73","source":"Crossref","is-referenced-by-count":11,"title":["Management of Xerostomia and Other Complications of Sj\u00f6gren's Syndrome"],"prefix":"10.1016","volume":"26","author":[{"given":"Andres","family":"Pinto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.coms.2013.09.010_bib1","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1002\/art.11199","article-title":"Treatment of primary Sjogren's syndrome with low-dose human interferon alfa administered by the oromucosal route: combined phase III results","volume":"49","author":"Cummins","year":"2003","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.coms.2013.09.010_bib2","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/S0011-8532(02)00023-X","article-title":"Treatment of xerostomia: a systematic review of therapeutic trials","volume":"46","author":"Brennan","year":"2002","journal-title":"Dent Clin North Am"},{"issue":"9","key":"10.1016\/j.coms.2013.09.010_bib3","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1007\/s00296-011-2085-6","article-title":"Evaluation of the clinical efficacy of Biotene Oral Balance in patients with secondary Sjogren's syndrome: a pilot study","volume":"32","author":"Aliko","year":"2012","journal-title":"Rheumatol Int"},{"issue":"7650","key":"10.1016\/j.coms.2013.09.010_bib4","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"issue":"5","key":"10.1016\/j.coms.2013.09.010_bib5","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.jclinepi.2008.02.009","article-title":"A\u00a0new \u201cmechanistic-practical\u201d framework for designing and interpreting randomized trials","volume":"62","author":"Karanicolas","year":"2009","journal-title":"J\u00a0Clin Epidemiol"},{"issue":"5","key":"10.1016\/j.coms.2013.09.010_bib6","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1136\/jech.2010.119933","article-title":"The GRADE approach and Bradford Hill's criteria for causation","volume":"65","author":"Schunemann","year":"2011","journal-title":"J\u00a0Epidemiol Community Health"},{"issue":"1","key":"10.1016\/j.coms.2013.09.010_bib7","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/j.1601-0825.2006.01252.x","article-title":"Pilocarpine treatment in a mixed cohort of xerostomic patients","volume":"13","author":"Aframian","year":"2007","journal-title":"Oral Dis"},{"issue":"2","key":"10.1016\/j.coms.2013.09.010_bib8","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s00784-007-0159-3","article-title":"The efficacy of Xialine in patients with Sjogren's syndrome: a single-blind, cross-over study","volume":"12","author":"Alpoz","year":"2008","journal-title":"Clin Oral Investig"},{"issue":"5","key":"10.1016\/j.coms.2013.09.010_bib9","first-page":"392","article-title":"Saliva substitute in xerostomic patients with primary Sjogren's syndrome: a single-blind trial","volume":"35","author":"Alves","year":"2004","journal-title":"Quintessence Int"},{"issue":"12","key":"10.1016\/j.coms.2013.09.010_bib10","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1136\/annrheumdis-2011-201026","article-title":"Clinical efficacy of leflunomide in primary Sjogren's syndrome is associated with regulation of T-cell activity and upregulation of IL-7 receptor alpha expression","volume":"71","author":"Bikker","year":"2012","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.coms.2013.09.010_bib11","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1601-0825.2000.tb00316.x","article-title":"Long-term follow-up of patients treated with acupuncture for xerostomia and the influence of additional treatment","volume":"6","author":"Blom","year":"2000","journal-title":"Oral Dis"},{"issue":"1","key":"10.1016\/j.coms.2013.09.010_bib12","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.tripleo.2010.02.032","article-title":"Effects of hydroxychloroquine on salivary flow rates and oral complaints of Sjogren patients: a prospective sample study","volume":"110","author":"Cankaya","year":"2010","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"issue":"5","key":"10.1016\/j.coms.2013.09.010_bib13","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1136\/annrheumdis-2012-202754","article-title":"Rituximab modulates the expression of IL-22 in the salivary glands of patients with primary Sjogren's syndrome","volume":"72","author":"Ciccia","year":"2013","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"10.1016\/j.coms.2013.09.010_bib14","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1111\/j.1600-0714.2011.01038.x","article-title":"Effects of gustatory stimulants of salivary secretion on salivary pH and flow in patients with Sjogren's syndrome: a randomized controlled trial","volume":"40","author":"da Silva Marques","year":"2011","journal-title":"J\u00a0Oral Pathol Med"},{"issue":"5","key":"10.1016\/j.coms.2013.09.010_bib15","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/0030-4220(83)90096-8","article-title":"Effect of Sialor in treatment of xerostomia in Sjogren's syndrome","volume":"56","author":"Epstein","year":"1983","journal-title":"Oral Surg Oral Med Oral Pathol"},{"issue":"11","key":"10.1016\/j.coms.2013.09.010_bib16","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1001\/archinte.162.11.1293","article-title":"Cevimeline for the treatment of xerostomia in patients with Sjogren syndrome: a randomized trial","volume":"162","author":"Fife","year":"2002","journal-title":"Arch Intern Med"},{"issue":"1","key":"10.1016\/j.coms.2013.09.010_bib17","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1601-0825.2005.01161.x","article-title":"Impact of wearing an intra-oral lubricating device on oral health in dry mouth patients","volume":"12","author":"Frost","year":"2006","journal-title":"Oral Dis"},{"issue":"12","key":"10.1016\/j.coms.2013.09.010_bib18","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD008934","article-title":"Interventions for the management of dry mouth: topical therapies","author":"Furness","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"issue":"9","key":"10.1016\/j.coms.2013.09.010_bib19","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1136\/ard.2004.031393","article-title":"Lamivudine is not effective in primary Sjogren's syndrome","volume":"64","author":"Gescuk","year":"2005","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.coms.2013.09.010_bib20","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.homp.2005.03.002","article-title":"Effects of homeopathic treatment on salivary flow rate and subjective symptoms in patients with oral dryness: a randomized trial","volume":"94","author":"Haila","year":"2005","journal-title":"Homeopathy"},{"issue":"3","key":"10.1016\/j.coms.2013.09.010_bib21","first-page":"165","article-title":"Clinical trial of ambroxol (Mucosolvan) in Sjogren's syndrome","volume":"13","author":"Ichikawa","year":"1988","journal-title":"Tokai J Exp Clin Med"},{"issue":"2","key":"10.1016\/j.coms.2013.09.010_bib22","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1741-2358.2001.00087.x","article-title":"Effects of mouthrinses with linseed extract Salinum without\/with chlorhexidine on oral conditions in patients with Sjogren's syndrome. A double-blind crossover investigation","volume":"18","author":"Johansson","year":"2001","journal-title":"Gerodontology"},{"issue":"1","key":"10.1016\/j.coms.2013.09.010_bib23","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1067\/moe.2003.30","article-title":"A\u00a0pilot study to test the efficacy of oral administration of interferon-alpha lozenges to patients with Sjogren's syndrome","volume":"95","author":"Khurshudian","year":"2003","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"issue":"4","key":"10.1016\/j.coms.2013.09.010_bib24","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s10067-007-0723-x","article-title":"The efficacy of cevimeline hydrochloride in the treatment of xerostomia in Sjogren's syndrome in southern Chinese patients: a randomised double-blind, placebo-controlled crossover study","volume":"27","author":"Leung","year":"2008","journal-title":"Clin Rheumatol"},{"issue":"2","key":"10.1016\/j.coms.2013.09.010_bib25","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3109\/03009748809098766","article-title":"Xerostomia due to Sjogren's syndrome. Diagnostic criteria, treatment and outlines for a continuous dental care programme and an open trial with Sulfarlem","volume":"17","author":"Malmstrom","year":"1988","journal-title":"Scand J Rheumatol"},{"issue":"4","key":"10.1016\/j.coms.2013.09.010_bib26","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1002\/art.20146","article-title":"Inefficacy of infliximab in primary Sjogren's syndrome: results of the randomized, controlled Trial of Remicade in Primary Sjogren's Syndrome (TRIPSS)","volume":"50","author":"Mariette","year":"2004","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.coms.2013.09.010_bib27","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1002\/art.27314","article-title":"Effectiveness of rituximab treatment in primary Sjogren's syndrome: a randomized, double-blind, placebo-controlled trial","volume":"62","author":"Meijer","year":"2010","journal-title":"Arthritis Rheum"},{"issue":"12","key":"10.1016\/j.coms.2013.09.010_bib28","doi-asserted-by":"crossref","first-page":"938","DOI":"10.2169\/internalmedicine.38.938","article-title":"Efficacy of low-dose prednisolone maintenance for saliva production and serological abnormalities in patients with primary Sjogren's syndrome","volume":"38","author":"Miyawaki","year":"1999","journal-title":"Intern Med"},{"issue":"6","key":"10.1016\/j.coms.2013.09.010_bib29","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1007\/s10165-007-0627-2","article-title":"Efficacy and safety of mizoribine for the treatment of Sjogren's syndrome: a multicenter open-label clinical trial","volume":"17","author":"Nakayamada","year":"2007","journal-title":"Mod Rheumatol"},{"issue":"5","key":"10.1016\/j.coms.2013.09.010_bib30","first-page":"533","article-title":"LongoVital in the treatment of Sjogren's syndrome","volume":"17","author":"Pedersen","year":"1999","journal-title":"Clin Exp Rheumatol"},{"issue":"3","key":"10.1016\/j.coms.2013.09.010_bib31","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1002\/art.510","article-title":"A double-blind, randomized, placebo-controlled study of cevimeline in Sjogren's syndrome patients with xerostomia and keratoconjunctivitis sicca","volume":"46","author":"Petrone","year":"2002","journal-title":"Arthritis Rheum"},{"issue":"11","key":"10.1016\/j.coms.2013.09.010_bib32","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1002\/art.24903","article-title":"Clinical and histologic evidence of salivary gland restoration supports the efficacy of rituximab treatment in Sjogren's syndrome","volume":"60","author":"Pijpe","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.coms.2013.09.010_bib33","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1002\/art.21260","article-title":"Rituximab treatment in patients with primary Sjogren's syndrome: an open-label phase II study","volume":"52","author":"Pijpe","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.coms.2013.09.010_bib34","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/0030-4220(91)90491-T","article-title":"Effects of pilocarpine on salivary flow in patients with Sjogren's syndrome","volume":"72","author":"Rhodus","year":"1991","journal-title":"Oral Surg Oral Med Oral Pathol"},{"issue":"7","key":"10.1016\/j.coms.2013.09.010_bib35","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1093\/rheumatology\/kep104","article-title":"Treatment of\u00a0sicca symptoms with hydroxychloroquine in patients with Sjogren's syndrome","volume":"48","author":"Rihl","year":"2009","journal-title":"Rheumatology (Oxford)"},{"issue":"7","key":"10.1016\/j.coms.2013.09.010_bib36","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1002\/art.20299","article-title":"Etanercept in Sjogren's syndrome: a twelve-week randomized, double-blind, placebo-controlled pilot clinical trial","volume":"50","author":"Sankar","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.coms.2013.09.010_bib37","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1477-5751-6-11","article-title":"Effectiveness of low-dose doxycycline (LDD) on clinical symptoms of Sjogren's syndrome: a randomized, double-blind, placebo controlled cross-over study","volume":"6","author":"Seitsalo","year":"2007","journal-title":"J\u00a0Negat Results Biomed"},{"issue":"4","key":"10.1016\/j.coms.2013.09.010_bib38","doi-asserted-by":"crossref","first-page":"R129","DOI":"10.1186\/ar2018","article-title":"Epratuzumab (humanised anti-CD22 antibody) in primary Sjogren's syndrome: an open-label phase I\/II study","volume":"8","author":"Steinfeld","year":"2006","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"10.1016\/j.coms.2013.09.010_bib39","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/art.27766","article-title":"Efficacy and safety of an intraoral electrostimulation device for xerostomia relief: a multicenter, randomized trial","volume":"63","author":"Strietzel","year":"2011","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.coms.2013.09.010_bib40","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s10165-008-0141-1","article-title":"Efficacy and safety of rebamipide for the treatment of dry mouth symptoms in patients with Sjogren's syndrome: a double-blind placebo-controlled multicenter trial","volume":"19","author":"Sugai","year":"2009","journal-title":"Mod Rheumatol"},{"issue":"11","key":"10.1016\/j.coms.2013.09.010_bib41","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.3899\/jrheum.080370","article-title":"Parotid irrigation and cevimeline gargle for treatment of xerostomia in Sjogren's syndrome","volume":"35","author":"Takagi","year":"2008","journal-title":"J\u00a0Rheumatol"},{"issue":"10","key":"10.1016\/j.coms.2013.09.010_bib42","first-page":"402","article-title":"Treatment of primary Sjogren's syndrome with D-penicillamine: a pilot study","volume":"60","author":"ter Borg","year":"2002","journal-title":"Neth J Med"},{"issue":"8","key":"10.1016\/j.coms.2013.09.010_bib43","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1136\/ard.2006.060905","article-title":"Safety and efficacy of leflunomide in primary Sjogren's syndrome: a phase II pilot study","volume":"66","author":"van Woerkom","year":"2007","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.coms.2013.09.010_bib44","doi-asserted-by":"crossref","first-page":"R115","DOI":"10.1186\/ar2322","article-title":"Mycophenolate sodium treatment in patients with primary Sjogren syndrome: a pilot trial","volume":"9","author":"Willeke","year":"2007","journal-title":"Arthritis Res Ther"},{"issue":"10","key":"10.1016\/j.coms.2013.09.010_bib45","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/S0929-6646(09)60266-7","article-title":"Pilocarpine hydrochloride for the treatment of xerostomia in patients with Sjogren's syndrome in Taiwan\u2013a double-blind, placebo-controlled trial","volume":"105","author":"Wu","year":"2006","journal-title":"J\u00a0Formos Med Assoc"},{"issue":"1","key":"10.1016\/j.coms.2013.09.010_bib46","first-page":"96","article-title":"Etanercept in the treatment of patients with primary Sjogren's syndrome: a pilot study","volume":"31","author":"Zandbelt","year":"2004","journal-title":"J\u00a0Rheumatol"},{"issue":"2","key":"10.1016\/j.coms.2013.09.010_bib47","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1001\/archinte.159.2.174","article-title":"Pilocarpine tablets for the treatment of dry mouth and dry eye symptoms in patients with Sjogren syndrome: a randomized, placebo-controlled, fixed-dose, multicenter trial. P92-01 Study Group","volume":"159","author":"Vivino","year":"1999","journal-title":"Arch Intern Med"},{"issue":"Suppl 3","key":"10.1016\/j.coms.2013.09.010_bib48","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S1532-3382(12)70051-9","article-title":"Oral\u00a0manifestations of systemic autoimmune and inflammatory diseases: diagnosis and clinical management","volume":"12","author":"Mays","year":"2012","journal-title":"J\u00a0Evid Based Dent Pract"},{"issue":"2","key":"10.1016\/j.coms.2013.09.010_bib49","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/BF00300975","article-title":"The clinical effects of electrostimulation on salivary function of Sjogren's syndrome patients. A placebo controlled study","volume":"12","author":"Talal","year":"1992","journal-title":"Rheumatol Int"},{"issue":"5","key":"10.1016\/j.coms.2013.09.010_bib50","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s10165-008-0078-4","article-title":"Effect of the H2 receptor antagonist nizatidine on xerostomia in patients with primary Sjogren's syndrome","volume":"18","author":"Kasama","year":"2008","journal-title":"Mod Rheumatol"},{"issue":"2","key":"10.1016\/j.coms.2013.09.010_bib51","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.anl.2004.01.005","article-title":"Taste function in Sjogren's syndrome patients with special reference to clinical tests","volume":"31","author":"Negoro","year":"2004","journal-title":"Auris Nasus Larynx"},{"issue":"4","key":"10.1016\/j.coms.2013.09.010_bib52","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/0030-4220(93)90172-Z","article-title":"Mucin-containing lozenges in the treatment of intraoral problems associated with Sjogren's syndrome. A double-blind crossover study in 42 patients","volume":"75","author":"Gravenmade","year":"1993","journal-title":"Oral Surg Oral Med Oral Pathol"},{"issue":"1","key":"10.1016\/j.coms.2013.09.010_bib53","first-page":"55","article-title":"Candida-related denture stomatitis: a pilot study of the efficacy of an amorolfine antifungal varnish","volume":"18","author":"Milillo","year":"2005","journal-title":"Int J Prosthodont"},{"issue":"1","key":"10.1016\/j.coms.2013.09.010_bib54","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1741-2358.2007.00137.x","article-title":"Measuring change in dry-mouth symptoms over time using the Xerostomia Inventory","volume":"24","author":"Thomson","year":"2007","journal-title":"Gerodontology"}],"container-title":["Oral and Maxillofacial Surgery Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1042369913001192?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1042369913001192?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,3]],"date-time":"2019-08-03T21:50:01Z","timestamp":1564869001000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1042369913001192"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["S1042369913001192"],"URL":"https:\/\/doi.org\/10.1016\/j.coms.2013.09.010","relation":{},"ISSN":["1042-3699"],"issn-type":[{"value":"1042-3699","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]}}}